Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Rejuvenation Research|January 11, 2012
Phenolic secoiridoids in extra virgin olive oil impede fibrogenic and oncogenic epithelial-to-mesenchymal transition: extra virgin olive oil as a source of novel antiaging phytochemicalsAlejandro Vazquez-Martin, Salvador Fernández-Arroyo, Sílvia Cufí, et al.Aging|July 28, 2012
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugsBruna Corominas-Faja, Rosa Quirantes-Piné, Cristina Oliveras-Ferraros, et al.International Journal of Oncology|April 2, 2011
Crude phenolic extracts from extra virgin olive oil circumvent de novo breast cancer resistance to HER1/HER2-targeting drugs by inducing GADD45-sensed cellular stress, G2/M arrest and hyperacetylation of Histone H3Cristina Oliveras-Ferraros, Salvador Fernández-Arroyo, Alejandro Vazquez-Martin, et al.Plos One|October 15, 2013
Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherinJuan Manuel Iglesias, Izaskun Beloqui, Francisco Garcia-Garcia, et al.Investigational New Drugs|December 17, 2010
Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cellsCristina Oliveras-Ferraros, Anna Massaguer Vall-Llovera, Dolors Carrion Salip, et al.Cell Cycle (Georgetown, Tex.)|December 21, 2012
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin)Begoña Martin-Castillo, Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, et al.International Journal of Oncology|July 29, 2010
Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin)Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Begoña Martin-Castilló, et al.Biochemical and Biophysical Research Communications|March 16, 2011
Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapiesCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Sílvia Cufí, et al.Cell Cycle (Georgetown, Tex.)|February 16, 2012
Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cellsAlejandro Vazquez-Martin, Luciano Vellon, Pedro M Quirós, et al.Aging|June 14, 2016
Mitophagy-driven mitochondrial rejuvenation regulates stem cell fateAlejandro Vazquez-Martin, Chris Van den Haute, Sílvia Cufí, et al.Pageof 8